Related Content
Aug. 25, 2025 β Amgen has announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of ...
August 26, 2025
September 12, 2023 β The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is ...
September 12, 2023
March 4, 2022 β NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of ...
March 04, 2022
May 18, 2021 β The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a ...
May 18, 2021
October 31, 2018 β Amgen announced a new Repatha cardiovascular outcomes study (FOURIER) analysis evaluating the effects ...
October 31, 2018
April 3, 2017 β There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes ...
April 03, 2017
March 20, 2017 β The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology annual ...
March 20, 2017
April 16, 2015 β The U.S. Food and Drug Administration (FDA) approved Amgenβs ivabradine (Corlanor) to reduce ...
April 16, 2015